Increased serum levels of macrophage migration inhibitory factor in patients with primary Sjögren's syndrome.

MLA

Willeke, Peter, et al. “Increased Serum Levels of Macrophage Migration Inhibitory Factor in Patients with Primary Sjögren’s Syndrome.” Arthritis Research & Therapy, vol. 9, no. 2, 2007, p. R43. EBSCOhost, https://doi.org/10.1186/ar2182.

APA

Willeke, P., Gaubitz, M., Schotte, H., Maaser, C., Domschke, W., Schlüter, B., & Becker, H. (2007). Increased serum levels of macrophage migration inhibitory factor in patients with primary Sjögren’s syndrome. Arthritis Research & Therapy, 9(2), R43. https://doi.org/10.1186/ar2182

Chicago

Willeke, Peter, Markus Gaubitz, Heiko Schotte, Christian Maaser, Wolfram Domschke, Bernhard Schlüter, and Heidemarie Becker. 2007. “Increased Serum Levels of Macrophage Migration Inhibitory Factor in Patients with Primary Sjögren’s Syndrome.” Arthritis Research & Therapy 9 (2): R43. doi:10.1186/ar2182.